These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6360050)

  • 41. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
    Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).
    Kizu R; Nakanishi T; Miyazaki M; Tashiro T; Noji M; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Kidani Y
    Anticancer Drugs; 1996 May; 7(3):248-56. PubMed ID: 8791997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
    Kido Y; Khokhar AR; Yoshida M; Thai GW; Siddik ZH
    Drug Metab Dispos; 1994; 22(2):312-7. PubMed ID: 8013287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
    Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity and nephrotoxicity of a novel platinum complex, [1,3-bis(diphenylphosphino)propane](trans-1-dach)platinum(I I) dinitrate.
    Baek MS; Rho YS; Jung JC; Chang SG; Nomura M; Miyamoto KJ
    Anticancer Res; 1997; 17(2A):955-9. PubMed ID: 9137434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
    Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nephrotoxicity and myelotoxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in rats].
    Horn U; Härtl A; Neuhaus G; Stöckel U; Schröer HP; Hoffmann H
    Arch Geschwulstforsch; 1989; 59(4):245-50. PubMed ID: 2802932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M; Cafaggi S; Parodi B; Esposito M
    Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability.
    M M; Chhatar S; Gadre S; Paul S; Vaidya SP; Khatri S; Duari P; Kode J; Ingle A; Kolthur-Seetharam U; Patra M
    Chemistry; 2024 Jan; 30(4):e202302720. PubMed ID: 37888749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
    Steerenberg PA; Storm G; de Groot G; Claessen A; Bergers JJ; Franken MA; van Hoesel QG; Wubs KL; de Jong WH
    Cancer Chemother Pharmacol; 1988; 21(4):299-307. PubMed ID: 3370737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of second generation platinum cytostatics on mammalian cell proliferation.
    Keprtová J; Smutná A; Minárová E; Vrána O
    Neoplasma; 1990; 37(2):121-9. PubMed ID: 2188163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S; Zeller WJ
    Cancer Res; 1991 Jun; 51(11):2943-8. PubMed ID: 2032232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative cytotoxicity between cisplatin and second generation platinum analogs.
    Drewinko B; Yang LY; Trujillo JM
    Invest New Drugs; 1985; 3(4):335-40. PubMed ID: 3910609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum.
    Mathé G; Kidani Y; Segiguchi M; Eriguchi M; Fredj G; Peytavin G; Misset JL; Brienza S; de Vassals F; Chenu E
    Biomed Pharmacother; 1989; 43(4):237-50. PubMed ID: 2675999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.